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Dual-seq transcriptomics 
reveals the battle for iron during 
Pseudomonas aeruginosa acute 
murine pneumonia
F. Heath Damron1, Amanda G. Oglesby-Sherrouse2,3, Angela Wilks2,3 & Mariette Barbier1
Determining bacterial gene expression during infection is fundamental to understand pathogenesis. 
In this study, we used dual RNA-seq to simultaneously measure P. aeruginosa and the murine host’s 
gene expression and response to respiratory infection. Bacterial genes encoding products involved in 
metabolism and virulence were differentially expressed during infection and the type III and VI secretion 
systems were highly expressed in vivo. Strikingly, heme acquisition, ferric-enterobactin transport, 
and pyoverdine biosynthesis genes were found to be significantly up-regulated during infection. In the 
mouse, we profiled the acute immune response to P. aeruginosa and identified the pro-inflammatory 
cytokines involved in acute response to the bacterium in the lung. Additionally, we also identified 
numerous host iron sequestration systems upregulated during infection. Overall, this work sheds light 
on how P. aeruginosa triggers a pro-inflammatory response and competes for iron with the host during 
infection, as iron is one of the central elements for which both pathogen and host fight during acute 
pneumonia.
Pseudomonas aeruginosa is an opportunistic Gram-negative respiratory pathogen of major clinical significance 
causing acute and chronic respiratory infections as well as bloodstream, urinary tract, burn wound, and surgical 
site infections1. According to the Center for Disease Control (CDC), 51,000 healthcare-associated P. aeruginosa 
infections occur in the United States each year2. This bacterium is highly versatile, able to survive in harsh envi-
ronments, and forms robust biofilms that are difficult to eradicate on medical devices. P. aeruginosa is inherently 
highly resistant to antibiotics, and effective antimicrobial treatment of infections caused by this bacterium is often 
challenging. Multidrug-resistant Pseudomonas cause 13% of all P. aeruginosa infections and were given a threat 
level of “serious” in the CDC Antibiotic Resistance Threat report in 20132. Overall, P. aeruginosa carries one of 
the highest case fatality rates of all Gram-negative infections3. The success of this microorganism is associated 
with its highly adaptive genome, ability to survive and thrive in diverse environments and the expression of a 
wide variety of virulence factors4–6. It is therefore important to develop new therapeutics for the treatment of 
P. aeruginosa infections.
To accomplish this objective, it is crucial to better understand the simultaneous pathogen and host transcrip-
tional responses during infection. Several studies have attempted to define the interaction dynamics between 
the pathogen and the host by studying gene and protein expression of either one or the other7–11. These studies 
have identified P. aeruginosa genes and virulence factors involved in bacterial attachment during colonization, 
nutrient acquisition, biofilm formation, or resistance to the immune system to facilitate persistence. Numerous 
studies have also identified how the host responds to infection12–14 and shown that pathogen-host interaction 
drives the selection and co-evolution of the two organisms15–17. More recently, Westermann et al. performed the 
first dual-RNA sequencing during tissue culture infection, demonstrating that dual-RNA sequencing is possible 
and a great tool to study pathogen-host interactions18.
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However, none of these studies have characterized simultaneously the bacterial and host molecular factors 
involved in acute lung infection. It has been hypothesized that sequencing the RNA of both the host and the 
pathogen during in vivo infection would be feasible19–21 and was recently accomplished during Toxoplasma gondii 
infections22. Advances in DNA and protein sequencing during the past decade have now made dual analysis of 
RNA and protein expression possible, even in complex tissues. To characterize the armamentarium used in the 
battle between P. aeruginosa and the host during acute lung infection, we developed a methodology using dual 
RNA-seq to identify the transcriptional response of the pathogen and the host during infection.
Results
Dual genome-wide gene expression analysis during infection. In this study, we hypothesized that 
in vivo conditions influence gene expression in P. aeruginosa during infection and that the bacterium elicits tran-
scriptional changes in the host. To test this hypothesis, we used a murine model of acute pneumonia to character-
ize the differences in P. aeruginosa gene expression during respiratory infection compared to in vitro growth. Using 
dual RNA-seq, we also gained insights into the effects of the bacterium on the host transcriptome. P. aeruginosa 
PAO1 was grown on Pseudomonas isolation agar (PIA) at 37 °C and 2 × 108 colony forming units (CFU) were 
used to infect outbred CD-1 mice by intranasal administration. The P. aeruginosa PAO1 grown on PIA was used 
to purify RNA for in vitro growth control. Mice were infected with PAO1, or PBS as control. After 16 h, mice 
were euthanized, lungs were removed and total RNA was purified. rRNA was depleted, and three libraries were 
Figure 1. Characterization of P. aeruginosa gene expression in vitro and in vivo. (a) Primary cellular 
localization of the products of the genes of P. aeruginosa PAO1 differentially regulated in vivo and in vitro. The 
percentage of the total number of genes whose expression was significantly up-regulated in vivo compared to  
in vitro are represented on the left; the percentage of genes whose expression was significantly up-regulated 
in vitro compared to in vivo are represented on the right. Genes were classified according to their known and 
predicted cellular localization. (b) Hypergeometric test enrichment analysis on annotation of P. aeruginosa 
PAO1 genes differentially regulated in vitro and in vivo. Data are represented as the percentage of genes (hits) in 
each class which expression was significantly up-regulated in vitro (green) or in vivo (blue). The subsets in which 
the number of hits was significant are denoted with asterisks (***p < 0.001). STRING analysis representing the 
300 most highly upregulated P. aeruginosa PAO1 genes expressed in vitro (c) or in vivo (d). Gene products are 
represented with circles and known associations between each gene or gene products are represented with a 
connecting line. Nodes of genes participating in similar functions are circled in green (expressed in vitro) or in 
blue (expressed in vivo).
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prepared and sequenced using the Illumina MiSeq platform. Read data were mapped to P. aeruginosa and Mus 
musculus genomes independently with CLC Genomics.
A total of 87 million 2 × 75 bp reads were obtained. In samples from in vitro culture of PAO1 on PIA, 83% 
of the reads mapped to the pathogen, with a total coverage of 99.1% of the open reading frames of P. aeruginosa 
PAO1. In infected mice, 11% of the reads mapped to P. aeruginosa, covering 98.2% of the transcriptome, and 64% 
of the reads mapped to the mouse transcriptome. A total of 78% of the reads mapped to the non-infected mouse 
control. These data indicate that the methodology used in this study provides quality RNA in sufficient quantity 
to study the transcriptomes of both the pathogen and the host in the same sample.
P. aeruginosa gene expression changes during infection. Global changes in P. aeruginosa gene expression. 
EDGE statistical analysis was used to measure differences in gene expression. A total of 1,887 P. aeruginosa genes 
were found to be up-regulated and 1,325 down-regulated in vivo compared to in vitro growth on PIA with a p 
value < 0.001 (Table S1). To define the systems differentially regulated in each experimental condition, data were 
analyzed using a wide range of metagenomics analysis tools including GO term analysis of the biological pro-
cesses, hypergeometric tests on annotations, PseudoCAP, KEGG pathways and STRING analysis23–26.
Cellular localization analysis of the gene products expressed by P. aeruginosa indicates that the proportion 
of differentially regulated genes whose products are localized in the cytoplasm, cytoplasmic membrane, peri-
plasm, outer-membrane, and extracellular compartment did not significantly change in vitro and during infection 
(Fig. 1a). However, genes whose products are associated with outer-membrane vesicles (OMV) were significantly 
up-regulated during infection (29 genes associated with OMV formation or OMV-localized products in vitro 
against 163 genes in vivo, Table S2). OMVs are produced under stress conditions27 and various authors suggested 
that OMVs are involved in resistance to the host immune system by absorbing antimicrobial compounds and 
complement28, providing a decoy membrane in the environment29 and delivering virulence factors to host cells 
during infection30. Our data seem to indicate that OMV-associated proteins are also important during acute 
respiratory infection.
Changes in gene expression associated with bacterial metabolism. STRING and metabolic analyses indicate that 
DNA replication, arginine deiminase pathway, gluconeogenesis, cobalamin and choline metabolism, putrescine 
transport, and polysaccharide biosynthesis processes were significantly up-regulated during infection (Fig. 1b,d). 
These results suggest, as other have previously hypothesized11, that various amino-acids such as arginine, lysine and 
proline are available in vivo, and that P. aeruginosa also synthesizes many essential amino-acids during infection. 
Genes involved in phenylalanine and cellular amide catabolism, as well as cysteine and unsaturated fatty acid bio-
synthesis were significantly up-regulated in vitro. Expression of genes from the region PA21XX31, whose products 
are involved in carbohydrate metabolism, and alginate production, and of other genes involved in stress response 
such as hypochlorite, oxidative stress, and arsenic-containing substances, were significantly increased in vitro, 
potentially as a result of the stringent growth conditions encountered in PIA (Fig. 1b,c). Pyocyanin expression 
was also found to be up-regulated in vitro, likely as a result of the high magnesium chloride and potassium sulfate 
Figure 2. Differential expression of bacterial secretion systems in vitro and in vivo. P. aeruginosa secretion 
systems expressed in vitro and in vivo were identified using the Kyoto Encyclopedia of Genes and Genomes 
(KEGG)24. Proteins encoded by genes up-regulated in vitro are indicated in green while proteins encoded by 
genes up-regulated in vivo are shown in blue.
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concentrations in PIA32. Overall these data suggest that P. aeruginosa adapts to changes in nutrient availability 
during infection, primarily as a result of its wide array of metabolic genes.
Non-coding RNA expression during infection. P. aeruginosa encodes within its genome numerous non-coding 
RNAs (ncRNA) involved in gene translation such as ribosomal RNAs and transfer RNAs. Other ncRNAs are 
involved in post-transcriptional regulation such as crcZ, nalA, phrS, prrF1, prrF2, rsmY, and rsmZ33–35. The expres-
sion of crcZ, prrF1, rsmY and rsmZ was detected both in vitro and during infection (RPKM values between 9 and 
97,710) (Table S1). The largest number of transcripts detected for a ncRNA in both datasets belonged to crcZ. This 
ncRNA is involved in carbon catabolite repression33,36 and was significantly down-regulated during infection (15 
fold). The expression of the gene encoding for the RNA chaperone Hfq (− 1.4 fold) was also found to be signifi-
cantly down-regulated during infection (Table S1). Altogether, these data suggest that decreased expression of hfq 
and crcZ might play a role in carbon utilization changes observed during infection. rsmZ was the smallest ncRNA 
detected (116 bp), suggesting that the method used in this study for RNA extraction and sequencing allows for 
detection of small ncRNA expression during infection. However, since the RNA extraction method used in this 
study is optimal for fragments over the size of 200 bp, specialized purification procedures designed for RNA frag-
ments of smaller sizes would likely enhance the characterization of small ncRNAs in this type of samples.
Expression of virulence factors during infection. P. aeruginosa encodes a wide variety of virulence 
factors for host colonization and to establish infections. As expected, we observed changes in P. aeruginosa vir-
ulence gene expression during acute murine pneumonia. The expression of genes encoding P. aeruginosa type 
III (T3SS) and type VI (T6SS) secretion systems which translocate effectors across the bacterial cell envelope 
and the eukaryotic cell membrane was significantly increased in vivo (Fig. 2, Table S1). The expression of genes 
encoding the T3SS secreted effectors ExoS, ExoT, and ExoY was also up-regulated during infection. These two 
systems are involved in eukaryotic cell targeting and P. aeruginosa virulence in vivo37,38. It is important to note 
that T3SS and T6SS are usually known to be inversely controlled. Genes encoding the type I and type II secretion 
systems were more predominantly expressed in vitro (Fig. 2). Other genes encoding virulence factors such as the 
potent exotoxin A (toxA, 5.3 fold) or flagellar biosynthesis (1.62 to 3.55 fold) were up-regulated during infection. 
Unlike what was observed in burn wound infections11, the expression of the majority of the genes involved in 
LPS biosynthesis (PA3146-PA3159; 1.55 to 3.51 fold) were also up-regulated during infection. However, mul-
tiple genes associated with virulence, which would have been predicted to be expressed during infection, were 
found to be down-regulated in vivo. For instance, the genes encoding the LasR and RhlR systems involved in 
quorum sensing (QS) and regulation of numerous virulence factors were significantly down-regulated in vivo 
compared to in vitro conditions. Not surprisingly, 82 QS-regulated genes identified by Wagner et al.39 were also 
down-regulated, representing 46% of the QS regulon. This set includes genes involved in the biosynthesis of 
virulence factors such as alkaline protease (− 1.67 to − 4.70 fold), elastase (lasB, − 154. fold) and protease IV (piv, 
− 2.04 fold) (Table S1). This result might be due to differences in cell density between in vitro plate and in vivo 
growth conditions. Other non-QS regulated virulence factors were also down-regulated such as phospholipase C 
(plcB, − 14.98 fold), alginate biosynthesis enzymes (− 2.47 to − 7.8 fold), and phenazines (− 7.81 to − 107.97 fold) 
Figure 3. Comparison between host proteomes and transcriptomes in response to P. aeruginosa infection. 
Ingenuity Pathway Analysis (IPA) of canonical pathways significantly up-regulated during P. aeruginosa 
infection detected by transcriptome analysis. Murine genes significantly up- or down-regulated during infection 
were analyzed using IPA and classified according to their known and predicted function.
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(Table S1). These genes have been shown to be important for P. aeruginosa virulence in various models including 
keratitis40, burn wound infections41, or chronic respiratory infections42,43. Decreased expression of these virulence 
factors, together with the changes in T3SS and T6SS expression, could be associated with the down regulation 
during infection of the two-component system GacA/GacS (− 2.0 and − 1.5 fold respectively) which controls both 
acute and chronic virulence determinants such as biofilm formation, T6SS, or exopolysaccharide production44–46. 
The gene encoding RetS, which controls the planktonic lifestyle and coordinates the production of toxins and the 
T3SS through the small RNAs rsmZ and rsmY47, was significantly upregulated in vivo. Interestingly, the expres-
sion of the gene encoding for the lost adherence sensor LadS was not significantly changed during infection. 
Additionally, increases in expression of both T3SS and T6SS during infection could also be associated with pop-
ulation heterogeneity and changes in expression of other regulatory element, such as the up-regulation of the 
contact-dependent PpkA (3.13 fold) regulation of T6SS44. The results obtained here suggest that some virulence 
factors might not be required for acute pulmonary infections, but might be expressed in later stages, for instance, 
in association with biofilms in chronic lung infections44,48.
M. musculus host response during infection. During infection, various host factors come 
into play to control and eliminate bacterial pathogens. To better understand the expression of these 
factors, EDGE statistical analysis was used to measure differences in gene expression in the lung of 
non-infected mice and mice infected with P. aeruginosa. The expression of 551 M. musculus genes 
increased and the expression of 151 decreased during infection compared to non-infected animals with a 
p value < 0.001. Meta-analysis of the data using hyper-geometric tests indicated that 80% of the genes with 
increased expression during infection were associated with pro-inflammatory response, chemotaxis, response 
to antigens, stress response, and regulation of cell proliferation. Granulocyte colony-stimulating factor 
(G-CSF or CSF3) was the most up-regulated eukaryotic gene during infection with a fold change of 706.23 
(p = 8.93 × 10−104). The expression of genes encoding other cytokines were also significantly increased during 
infection, including the pro-inflammatory cytokines IL1, IL8, tumor necrosis factor alfa (TNF-α ), interferon 
gamma (IFN-γ ), and CSF2. CXC-motif chemokines (CXCL1, 2, 5, 9, 10 and 16), CC-motif chemokines (CCL2, 
3, 4, 5, 7, 9, 11, 17 and 20), and the chemokine receptors IL1R2, IL4R, IL17R, and IL18RAP. The genes encoding 
FAS and TNFR2 were also highly expressed during infection, together with genes whose products are involved 
in TNF and NFκ B signaling (Fig. 3, Table S3). These changes in chemokine expression were likely due to LPS 
and flagellin recognition by the Toll-like receptors (TLR) 2 and 449–53. The genes encoding CD14 (42.55 fold) and 
MyD88 (5.54 fold), two proteins involved in signaling trough TLR4, had increased expression levels during infec-
tion (Fig. 3, Table S3). The expression of the gene encoding TLR2, associated with susceptibility to P. aeruginosa 
infections54, was also found to be up-regulated during infection (10.85 fold). These data are in agreement with 
findings from numerous studies highlighting the importance of Toll-like receptors (TLR) in the recognition of 
P. aeruginosa during infection55–59. Interestingly, while T3SS effectors, such as ExoS have been shown to inhibit 
the expression of IL-1β 60, the expression of this chemokine was up-regulated in vivo (13.69 fold). Altogether, 
chemokine expression is responsible for leukocyte differentiation, activation and recruitment, the production 
and release of pro-inflammatory cytokines, and play a major role in host defense against P. aeruginosa9. These 
chemokines can also be sensed by P. aeruginosa proteins such as OprF and affect gene expression in response to 
proinflammatory signals61.
Figure 4. Role of HasR on bacterial burden in mice during acute infection. Mice were infected intranasally 
with 108 CFU of PAO1Δ hasR and the parental PAO1 strain. Bacterial burden were determined in the nares 
and lung 16 hours post infection. Lung were resuspended in 1 ml PBS and nasal washes were performed with 
1 ml of PBS. Data are represented as number of CFU detected in the total volume of sample. Experiments were 
performed with 6 mice per group and four technical replicates. Data were analyzed using a two-tailed student 
t-test and the software package Graphpad Prism. Statistically significant differences are denoted with asterisks 
(*p < 0.05; ***p < 0.0001).
www.nature.com/scientificreports/
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Battle for iron during infection. P. aeruginosa iron acquisition during infection. Iron is a vital nutrient 
involved in a wide range of biological processes and enzymatic functions. In low iron conditions, P. aeruginosa 
uses siderophores such as pyoverdine and pyochelin to chelate free extracellular Fe3+ 62–64. Pyoverdine binds Fe3+ 
to form ferripyoverdine. The fpvA gene encodes the ferripyoverdine TonB-dependent receptor (TBDR) FpvA. 
This receptor is bound to the anti-σ factor FpvR that sequesters the σ factors PvdS and FpvI to the bacterial 
membrane. Binding of ferripyoverdine to FpvA triggers the proteolysis of FpvR, releasing PvdS and FpvI. These 
σ factors then associate with the RNA polymerase and drive the expression of fpvA and the genes responsible for 
pyoverdine biosynthesis65,66. In our RNA-seq analysis, the expression of fpvA was increased in vivo (7.41 fold), 
while the expression levels of fpvI, fpvR and pvdS were unchanged (Table S1). This result suggests that in vivo, fer-
ripyoverdine binding to FpvA triggers the release of PvdS and FpvI. As a result, pyoverdine expression levels are 
significantly up-regulated during infection (pvdADEFGHJLNOPQRT), supporting established in vitro models65,66. 
The gene expression of the alternative ferripyoverdine receptor, encoding FpvB, was also up-regulated in vivo 
(4.86 fold) (Table S1). Previous studies have shown the importance of the expression of this system in vivo; 
pyoverdine and FpvA mutants show decreased virulence compared to the parental strain in establishing murine 
pulmonary infections67,68. The expression of genes used to produce pyochelin, which has a lower affinity for iron 
than pyoverdine63, were also up-regulated in vivo. The pchABCD operon was expressed 40 to 50 fold more in vivo 
Figure 5. Iron scavenging and regulation in vivo. (a) Macrophages acquire iron via transferrin receptor 
(TRF)-mediated endocytosis of transferrin or via recycling of senescent erythrocytes. Macrophages degrade 
heme using heme oxygenase to generate iron, biliverdin and carbon monoxide. Iron is then transferred to the 
cytoplasm by DMT1 and either stored using ferritin or released using ferroportin (FPN). (b) During infection, 
bacterial recognition by pattern recognition receptors triggers activation of Toll-like receptors (TLR) and 
secretion of pro-inflammatory cytokines. As a result, cell release hepcidin to control iron release by FPN. 
Proinflammatory cyctokines are also involved in the regulation of Nramp1, which together with FPN deprives 
internalized bacteria of iron. TNF-α , IL-1 and IL-6 also stimulate the storage of iron using ferritin. (c) During 
infection, bacteria can lyse erythrocytes using various hemolysins and toxins to release heme and hemoglobin. 
The host re-captures these iron-rich proteins using haptoglobin and hemopexin, while P. aeruginosa secretes 
hemophores such as HasA for heme scavenging. (d) The host uses lactoferrin and transferrin to limit iron 
availability during infection. P. aeruginosa secretes siderophores with a high iron affinity such as pyoverdine 
to circumvent iron sequestration. In response, the host releases siderocalin/lipocalin-2 to neutralize bacterial 
siderophores. Elements that were found to be up-regulated during P. aeruginosa infection in the lung are 
indicated in bold black letters. Elements that were unchanged are shown in grey.
www.nature.com/scientificreports/
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than in vitro and the genes pchREFG were expressed over 20 fold more in vivo. pchA was found amongst the genes 
most highly expressed in vivo (Table S1).
P. aeruginosa is also able to obtain heme from hemoproteins using the Has and Phu sytems69,70. In the Has 
system, the heme is extracted by the hemophore HasAp, which delivers the iron through the TBDR HasR. In the 
Phu system, the TBDR PhuR directly extracts the heme. In both pathways, heme is then transported to the cyto-
plasm by an ABC transporter, bound to a heme chaperone, PhuS, before being delivered to the heme oxygenase 
HemO71. In this RNA-seq study, hasAp was the most highly expressed gene in vivo, with differences in expression 
of 317.43 fold compared to in vitro settings. The genes hasD (228.00 fold), hasE (177.53 fold), hasR (72.16 fold), 
phuR (27.42 fold), phuS (15.00 fold), and hemO (6.39 fold) were also highly expressed in vivo (Table S1). HemO 
expression was shown to be necessary to drive the metabolic flow of heme into the cell, with PhuS participating 
in heme sensing and acting as a control valve for heme intake and degradation72. Overall, the Has heme acqui-
sition system was the most highly expressed set of genes in vivo, suggesting the importance of iron acquisition 
from heme during infection. To validate these findings and determine the contribution of the Has system to 
P. aeruginosa pathogenesis, 6 weeks old female CD1 mice were infected intranasally with 108 CFU of PAO1Δ hasR 
or the parental strain PAO1. Sixteen hours post infection, mice were euthanized by pentobarbital injection and 
the bacterial load in the respiratory tract was determined. In this model of acute respiratory infection, the bacte-
rial load of PAO1Δ hasR was 18.89 fold lower in the lung, and 6.8 fold lower in the nasal washes than the parental 
strain (Fig. 4). These data indicate that a mutant lacking the heme receptor HasR was strongly attenuated during 
infection. Overall, both RNA-seq and animal infection data suggests, as other have hypothesized in the past73, 
that pyoverdine and the Has/Phu systems are involved in acute respiratory infections and play a major role in P. 
aeruginosa pathogenesis (Fig. 5).
Iron sequestration by the host during infection. One of the first lines of defense against bacterial infection is the 
sequestration of nutrients such as iron to inhibit bacterial growth. During acute infection, the host decreases iron 
release into the circulation via hepcidin, increases intracellular iron storage using ferritin, decreases extracellu-
lar non-heme iron levels via ceruloplasmin and lactoferrin, and decreases extracellular-heme iron levels using 
hemopexin and haptoglobin. Vertebrates also produce lipocalin-2, or neutrophil gelatinase-associated lipocalin 
(NGAL), which is secreted by neutrophils in response to infection, and captures bacterial siderophores. In this 
study, we observed that RNA levels of genes encoding for the expression of ferritin, ceruloplasmin, lactoferrin 
and haptoglobin are increased 4 to 20 fold during P. aeruginosa acute pneumonia (Table 1). However, no changes 
were observed in ferroportin, hepcidin, hemopexin, transferrin, or transferrin receptor expression. Additionally, 
the expression of norepinephrine, which increases iron availability, was decreased. These results seem to indicate 
that during P. aeruginosa infection, the host attempts to sequester iron from the pathogen to limit growth and 
dissemination (Fig. 5).
Discussion
In this study, we determined the changes in P. aeruginosa and host gene expression in the context of an acute 
murine pneumonia. As expected, we observed that P. aeruginosa expressed numerous virulence factors during 
infection, including T3SS and T6SS. P. aeruginosa was found to up-regulate outer membrane vesicle formation 
and modify its metabolism in response to infection. In the past, we observed that arginine metabolism responded 
to changes of temperature corresponding to the transition from the environment to the host7. In this dataset, we 
were able to confirm that arginine metabolism gene expression is also increased during infection, suggesting 
that P. aeruginosa adapts its metabolism in response to nutrient availability such as arginine. Overall, there is an 
important overlap between the data obtained here and gene expression changes observed in acute and chronic 
burn wounds infections11 (T3SS, T6SS, iron acquisition, amino-acid metabolism). This overlap suggests, as others 
have hypothesized, that while a core set of virulence genes are required to cause infection, P. aeruginosa adap-
tation to the lung requires the coordinated expression of genes involved in both virulence and metabolism11,74.
Infection with P. aeruginosa triggered a strong innate immune response and a cytokine storm mediated by 
TLR and MyD88 signaling. These data are in agreement with various studies showing that P. aeruginosa and 
outer-membrane vesicles are strong agonists of TLR pathogen-associated molecular pattern receptors75–77. 
Additionally, we observed that the expression of numerous host proteins involved nutritional immunity78 were 
increased during infection. In particular, proteins participating in iron sequestration were up-regulated during 
infection, including ferritin, ceruloplasmin, lactoferrin, and haptoglobin. Iron is an essential nutrient required 
by both mammalian hosts and pathogens, and the race for iron is undoubtedly crucial during infection. In the 
mammalian host, iron is not freely available and is bound to heme molecules found in hemoproteins or chelated 
by extracellular proteins such as lactoferrin and transferrin79. During infection, P. aeruginosa sequesters free 
iron using siderophores and scavenges iron from heme using the Has and Phu heme acquisition systems. One of 
the most striking observation in this study was the expression levels of the P. aeruginosa Has heme acquisition 
system during infection (over 300 fold up-regulated compared to in vitro conditions for hasAp). Pyoverdine and 
pyochelin siderophores, together with the Phu heme acquisition system were also up-regulated, suggesting that 
bacteria are starved for iron during infection. Up-regulation of both heme and siderophores systems in vivo is 
likely controlled by the master iron regulator Fur, as no significant changes in expression of the ncRNA prrF1,2 
and prrH were observed during infection80. Additionally, both HasAp and PhuS could also be involved in heme 
sensing and might be up-regulated during infection in response to the presence of heme in the lung72. Numerous 
studies have demonstrated the importance of siderophores in bacterial virulence and colonization81, and authors 
have shown that pyoverdine production can be detected in the sputum of CF patients82. It has also been shown 
that P. aeruginosa interaction with epithelial cells in vitro in presence of iron is sufficient to up-regulate pyo-
verdine acquisition genes83. Siderophores have a high affinity for iron, can displace iron from host NGAL and 
www.nature.com/scientificreports/
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transferrin for iron piracy, and have been shown to also act as toxins84. While others have suggested that other 
iron acquisition systems such as Has and Phu play a role in P. aeruginosa pathogenesis73, their use as an alternative 
iron acquisition system during infection has been underappreciated. The data presented here strongly suggests 
that heme acquisition by the Has/Phu systems play a crucial role for iron acquisition in vivo. Others have shown 
that iron and heme utilization by P. aeruginosa depends on disease progression, and suggested that heme acqui-
sition is characteristic of chronic P. aeruginosa infections85,86. Isolates from chronic CF respiratory infections 
were shown to become more efficient in heme utilization by up-regulating PrrF and HemO expression86. In our 
dataset, heme acquisition also seems to play a major role in acute infection. For this reason, it would be interesting 
to further define the timing and synergy of heme and iron acquisition systems in P. aeruginosa during infection. 
While siderophores have been used as a therapeutic target87,88, it is crucial to determine the therapeutic potential 
of heme acquisition inhibitors in P. aeruginosa. Seminal studies have paved the way to understand the role of gene 
expression in P. aeruginosa pathogenesis11,41,74. Current advances in technology now allow us to study bacterial 
pathogenesis from a more systematic approach19. We anticipate that the methodology described in this study will 
further our understanding of pathogen-host interactions and be applicable in a wide range of systems to facilitate 
the development of novel therapeutics.
Experimental procedures. Bacterial strains and growth media. P. aeruginosa type strain PAO1 was orig-
inally obtained from Dr. Michael L. Vasil (University of Colorado). PAO1Δ hasR was obtained from Dr. Angela 
Wilks70 (University of Maryland). P. aeruginosa was grown in Pseudomonas isolation agar (Becton Dickinson, 
Franklin Lakes, NJ) for 16h at 37 °C before infection.
Infection model. P. aeruginosa PAO1 was grown as described above. Bacteria were swabbed off the plate and 
resuspended in phosphate buffered saline (PBS) at a concentration of 1010 colony forming units (CFU) per ml. A 
fraction of that suspension was centrifuged and resuspended in RNA protect to measure bacterial gene expression 
in vitro before infection. Twenty outbred six weeks old female CD1 mice (Charles River, Frederick, MD) were 
anesthetized by injection of ketamine and xylazine. Ten microliters of the bacterial suspension were adminis-
tered to each nostril (108 CFU/mouse). Ten mice were infected with PAO1, and 10 mice were administered PBS 
vehicle control. Sixteen hours post-infection, mice were euthanized by exposure to carbon dioxide. Lungs were 
extracted from 4 mice per group and 3 immediately placed in bacterial RNA protect (Qiagen, Germantown, MD) 
to prevent RNA degradation. The remaining lung was homogenized in PBS and serial dilutions were plated to 
determine the load in the lung. Sixteen hours post infection, approximately 109 CFU were detected in the lung of 
each mouse (data not shown). To determine the role of hasR on P. aeruginosa pathogenesis, mice were infected as 
described above with 108 CFU of PAO1Δ hasR or the parental strain PAO1. After 16 hours of infection, mice were 
euthanized as described above, and nasal washes and lungs were obtained. Lungs were placed into 1 ml of PBS and 
homogenized. Nasal washes and lung homogenates were then diluted in PBS, and plated on Lysogeny agar (LA) 
to determine the number of viable bacteria. Data were analyzed using a two-tailed student t-test and the software 
package Prism 7 (GraphPad, La Jolla, CA). These experiments were performed in accordance with the National 
Institutes of Health guide for the care and use of laboratory animals. The protocols used were approved by the 
University of Virginia and West Virginia University Institutional Animal Care and Use Committees.
RNA purification and RNA-seq Illumina library preparation and sequencing. RNA was isolated from bacteria 




Lcn2 Lipocalin 2 30.85 8.34E-04
Ltf Lactotransferrin 14.34 2.16E-05
Fth1 Ferritin heavy chain 1 6.27 2.33E-03
Cp Ceruloplasmin 4.82 2.83E-05
Hba-a1 Hemoglobin alpha, adult chain 1 2.11 3.12E-03
Hba-a2 Hemoglobin alpha, adult chain 2 2.96 3.03E-04
Hbb-bs Hemoglobin beta adult s chain 2.07 1.98E-03
Hbb-bt Hemoglobin beta adult t chain 2.54 1.89E-04
Steap4 Metalloreductase able to reduce Fe3+ to Fe2+ using NAD+ as receptor 20.64 4.59E-05
Slc39a14 Soluble metal carrier protein 17.85 2.69E-05
Fbxl5 F-box and leucin-rich repeat protein 5, iron sensor 5.72 1.65E-05
Picalm Phosphatidylinositol binding clathri assembly protein, transferrin receptor internalization 3.74 3.45E-05
Scd2 Stearoyl-coenzyme A desaturase 2, iron binding and oxydoreductase activity − 1.9  5.54E-05
Mmp8 Metallopeptidase 8 34.28 2.57E-05
Mmp9 Metallopeptidase 9 13.82 2.28E-05
Table 1. Host iron-associated genes differentially regulated during P. aeruginosa infection. Fold changes 
were calculated by comparing infected to non-infected mice. Fold changes greater than 1 indicate that the gene 
was up-regulated during infection compared to in vitro growth conditions. Fold changes inferior to − 1 indicate 
that the gene was down-regulated during infection compared to in vitro growth conditions.
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Briefly, cells were pelleted by centrifugation at 8,000 g and RNA protect was pipetted off. Cell were lysed using 
200 μ l of TE lysozyme for 5 min at room temperature. Cells were then mixed with 700 μ l of RLT and 500 μ l of 70% 
ethanol. RNA was then applied to RNeasy purification columns and cleaned with RW1 and RPE buffers. RNA 
was eluted, treated with RNase-free DNase (Qiagen), and cleaned up on another RNeasy Mini column. RNA was 
isolated from the lung using the same kit with the following modifications: after removing the RNA protect, each 
lung was homogenized mechanically for 1 min in 667 μ l of TE with 1 mg/ml of lysozyme. A total of 2.33 ml of 
RLT buffer was then added and tissue was homogenized again for 1 min. Samples were centrifuged at 12,000 g for 
10 min and supernatant was transferred to a fresh tube. Five ml of 70% ethanol were added and RNA was purified 
using 12 RNeasy columns (2 columns per sample). Columns were cleaned with RW1 and RPE buffers, and RNA 
was eluted. The RNA extracted from the two columns per sample was pooled, treated with RNase-free DNase 
(Qiagen), and cleaned up using an RNeasy Mini column.
The resulting RNA was quantified on a Nanodrop ND-1000 (Nanodrop, Wilmington, DE). Next, the RNA 
integrity was assessed using Agilent BioAnalyzer RNA Pico chip (Agilent, Santa Clara, CA). All samples were then 
submitted to two rounds of eukaryotic and prokaryotic Ribo-zero rRNA depletion (Illumina, San Diego, CA) and 
reassessed for RNA integrity. rRNA depleted mRNA samples were then fragmented and prepared into libraries 
using Illumina TruSeq RNA library prep kit v2. Libraries were checked for quality control with KAPA qPCR QC 
assay (KAPA Biosystems, Wilmington, MA). The libraries were then sequenced on an Illumina MiSeq by the 
University of Virginia Department of Biology Genomics Core using Illumina MiSeq v3 2 × 75 bp reads. Three 
MiSeq lanes were used and each lane contained one biological sample of infected P. aeruginosa infected lung, one 
non-infected lung, and one P. aeruginosa in vitro sample. A total of three lanes were used to obtain for 81 million 
2 × 75 bp reads for the three biological replicates of each group. Sequencing data were deposited to the Sequence 
Read Archive (SRA) and are available under the reference number SRP090213, BioProject number PRJNA343201.
RNA-seq bioinformatics analyses. RNA-seq reads were analyzed using the software CLC Genomics workbench 
7.5.1 (Qiagen). The P. aeruginosa PAO1 genome and annotations were downloaded from the Pseudomonas 
Genome Database and Mus musculus genome was downloaded from NCBI. Reads were mapped against the 
gene regions of the two genomes using the following settings for mapping: mismatch cost = 2, insertion cost = 3, 
deletion cost = 3, length fraction = 0.8, similarity fraction = 0.8. RPKM values were generated using default 
parameters for CLC Genomics. Fold changes in gene expression and statistical analyses were performed using an 
Extraction of Differential Gene Expression (EDGE) test with the Bonferroni correction89.
Metabolic and gene set enrichment analyses. Genes with differences in gene expression with a p value < 0.001 
were mapped on the Kyoto Encyclopedia of Genes and Genomes using KEGG Mapper v.2.524. Gene set enrich-
ment analysis (GSEA) tests were performed using CLC Genomic workbench 7.5.123. Analyses were performed 
using gene ontology (GO) terms for biological processes25, with a total of 10,000 permutations. Primary cellular 
localization of the gene products was obtained from the P. aeruginosa PAO1 genome annotation downloaded 
from the Pseudomonas Genome Database. The 300 genes most highly up and down regulated in the P. aeruginosa 
PAO1 gene expression dataset were analyzed and grouped using the STRING 9.1 database of known and pre-
dicted interactions26 (string-db.org).
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